Investor Ideas Potcasts, Cannabis News and Stocks on the Move: (TSXV: KHRN) (CSE: DIXI.U) (OTCQX: DXBRF) (CSE: CBDT) (TSX: TGOD)

Delta, Kelowna, BC – August 7, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM – cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2019/080719-StocksToWatch.mp3

Hear Investor ideas cannabis potcast on iTunes

In today’s podcast we look at a few early announcements.

But first, Strainprint™ Technologies Ltd. has launched the next stage of the much-anticipated clinical trial with Israeli based research group Gynica to develop a product formulation to treat endometriosis and its symptoms. This phase will include asking endometriosis sufferers in Canada and Israel to complete an anonymous, comprehensive custom questionnaire about how they use cannabis to treat their symptoms.

Strainprint, the leader in cannabis data and analytics partnered with Israeli researchers at Gynica, a leader in cannabis-based solutions for women’s health, in

... read more at: https://www.investorideas.com/news/2019/cannabis-potcasts/08071KHRN-DIXI-DXBRF-CBDT-TGOD.asp

by